异土木香内酯通过bcr-abl-STAT5信号通路抑制慢性粒细胞白血病耐药细胞K562/A02增殖

目的 探讨异土木香内酯对慢性粒细胞白血病耐药细胞K562/A02增殖的抑制作用及其机制.方法6.25、12.5、25、50、100μmol/L的异土木香内酯作用于K562/A02细胞24、48 h,四甲基偶氮唑盐(MTT)法检测其对K562/A02细胞的增殖抑制效果;10、15、20μmol/L异土木香内酯作用于K562/A02细胞24 h,流式细胞术检测细胞周期及凋亡;Western blot法检测增殖相关蛋白表达水平.多组间比较采用单因素方差分析.结果异土木香内酯能够显著抑制K562/A02细胞增殖,并呈浓度依赖性(P<0.05),作用24 h的半数抑制浓度(IC50)值为(15.00±1.03)μmol/L;阴性对照组及10、15、20μmol/L异土木香内酯作用后K562/A02细胞凋亡率分别为(2.71±0.52)%、(19.10±1.55)%、(27.61±2.32)%和(32.01±3.01)%,呈浓度依赖性(F=33.901,P<0.05);S期细胞比例分别为(57.80±2.11)%、(68.62±2.89)%、(78.44±3.51)%和(80.61±2.90)%,呈浓度依赖性(F=51.328,P<0.05).异土木香内酯明显降低bcl-2、p-bcr-abl、p-STAT5、细胞周期蛋白依赖性激酶2(CDK2)和细胞周期蛋白A(cyclin A)的表达(P<0.05),上调细胞色素C、Bax和p21的表达(P<0.05).结论异土木香内酯能够通过bcr-abl-STAT5信号通路抑制K562/A02细胞增殖.

Isoalantolactone suppresses proliferation of chronic myelogenous leukemia drug-resistant cell line K562/A02 through bcr-abl-STAT5 signaling pathway

Objective To explore the effects of isoalantolactone on the proliferation of human chronic myelogenous leukemia drug-resistant cell line K562/A02. Methods K562/A02 cells were treated with 6.25, 12.5, 25, 50 and 100 μmol/L isoalantolactone for 24 and 48 h, cell viability was analyzed with MMT assay. K562/A02 cells were treated with 10, 15, 20 μmol/L isoalantolactone for 24 h. Flow cytometry was used to examine the effect of isoalantolactone on the cell-cycle and apoptosis of K562/A02 cells. The related proteins were analyzed using Western blot. One-way ANOVA was used for statistical analysis. Results Isoalantolactone effectively inhibited the proliferation of K562/A02 cells in a dose-dependent manner (P<0.05) with IC50 value of (15.00 ±1.03) μmol/L at 24 h, respectively; Flow cytometry displayed that isoalantolactone may induce K562/A02 cells apoptosis in a concentration-dependent manner (P<0.05). The apoptotic rate significantly increased from (2.71 ±0.52) % in the control group to (19.10 ±1.55) %, (27.61 ± 2.32)%and (32.01±3.01)%(F=33.901, P<0.05), respectively, after treatment with 10, 15, and 20 μmol/L of isoalantolactone for 24 h. The percentage of cells in the S phase increased from (57.80±2.11) % to (68.62± 2.89)%, (78.41±3.51)%and (80.61±2.90)%, respectively (F=51.328, P<0.05). Western blot indicated that the expression of bcl-2, p-bcr-abl, p-STAT5, CDK2 and cyclin A significantly decreased (P< 0.05), and that of cytochrome C, Bax, and p21 increased with the increasing of isoalantolactone concentration (P< 0.05). Conclusion Isoalantolactone can significantly inhibit the proliferation of K562/A02 cells through bcr-abl-STAT5 signaling pathway.